Ginkgo Biloba
Natural health product licensed in Canada
- Licence holder
- Orbus Pharma Inc.
- NPN or DIN-HM
- 80000241
- Status
- Active licence
- Licence date
- 5 January 2005
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Cire d'abeille, Glycérine, Lécithine, Dioxyde de titane, Jaune D & C No. 10, Oxyde de fer noir, Oxyde de fer rouge, FD & C bleu #1, Gélatine, Eau purifiée, Palm Stearine, Huile de fève de soja
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Helps to improve age-related memory and cognitive impairments.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult health care practitioner for prolonged use over 3 months.
- Contre-indications
Do not use if pregnant or breastfeeding. Do not use if you have a bleeding disorder. Do not use in children under the age of 12.
- Effets indésirables connus
Discontinue use if product causes mild gastrointestinal upset.
Source
Official Health Canada record, licence 80000241
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.